Daisuke Abe

AKI and Long-Term Risk for Cardiovascular Events and Mortality

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

High Turnover of Tissue Factor Enables Efficient Intracellular Delivery of Antibody–Drug Conjugates

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

Contribution of platelets to tumour metastasis

Acute kidney injury

The Role of Hepatocyte Nuclear Factor-1A in the Pathogenesis of Clear Cell Carcinoma of the Ovary

Thrombosis and cancer

Strategies and challenges for the next generation of antibody–drug conjugates

Classification, Functions, and Clinical Relevance of Extracellular Vesicles

Cancer-associated venous thromboembolism: Burden, mechanisms, and management

Endometriosis: pathogenesis and treatment

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer

Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention